(FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | (Q6)Sep 30, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | 37.48%-9.36M | ---- | 32.25%-14.97M | ---- | 19.21%-22.09M | ---- | -8.67%-27.34M | ---- | -573.97%-25.16M | ---- |
Profit adjustment | ||||||||||
Interest (income) - adjustment | -2.80%-367K | ---- | -0.28%-357K | ---- | 0.28%-356K | ---- | -181.10%-357K | ---- | -262.86%-127K | ---- |
Interest expense - adjustment | -84.42%576K | ---- | -34.25%3.7M | ---- | 19.82%5.62M | ---- | 22.18%4.69M | ---- | 88.01%3.84M | ---- |
Attributable subsidiary (profit) loss | 17.18%-2.98M | ---- | -8.88%-3.59M | ---- | 1.76%-3.3M | ---- | -525.33%-3.36M | ---- | 96.35%-537K | ---- |
Impairment and provisions: | -60.52%1.23M | ---- | -58.08%3.11M | ---- | -21.16%7.41M | ---- | 729.21%9.4M | ---- | 1,281.71%1.13M | ---- |
-Impairment of property, plant and equipment (reversal) | ---- | ---- | -64.79%1.89M | ---- | 4,001.53%5.37M | ---- | -75.70%131K | ---- | --539K | ---- |
-Impairmen of inventory (reversal) | -91.25%66K | ---- | 247.27%754K | ---- | -247.98%-512K | ---- | --346K | ---- | ---- | ---- |
-Impairment of trade receivables (reversal) | 133.93%38K | ---- | -918.18%-112K | ---- | ---11K | ---- | ---- | ---- | -300.00%-2K | ---- |
-Other impairments and provisions | 96.50%1.12M | ---- | -77.67%571K | ---- | -71.33%2.56M | ---- | 1,396.31%8.92M | ---- | 635.80%596K | ---- |
Revaluation surplus: | ---- | ---- | -89.14%49K | ---- | -82.26%451K | ---- | -63.21%2.54M | ---- | 224.22%6.91M | ---- |
-Derivative financial instruments fair value (increase) | ---- | ---- | -89.14%49K | ---- | -82.26%451K | ---- | --2.54M | ---- | ---- | ---- |
-Other fair value changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 224.22%6.91M | ---- |
Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --820K | ---- |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --810K | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --10K | ---- |
Depreciation and amortization: | -43.65%2.76M | ---- | -44.81%4.89M | ---- | 108.39%8.87M | ---- | -23.72%4.26M | ---- | 339.56%5.58M | ---- |
-Amortization of intangible assets | 70.87%176K | ---- | --103K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Exchange Loss (gain) | -16.31%2.36M | ---- | --2.82M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Special items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---40K | ---- |
Operating profit before the change of operating capital | -32.75%-5.78M | ---- | -28.18%-4.36M | ---- | 66.59%-3.4M | ---- | -34.12%-10.17M | ---- | 34.69%-7.59M | ---- |
Change of operating capital | ||||||||||
Inventory (increase) decrease | 128.75%2.62M | ---- | -1,447.12%-9.13M | ---- | -169.41%-590K | ---- | -127.44%-219K | ---- | 682.48%798K | ---- |
Accounts receivable (increase)decrease | -133.76%-3.97M | ---- | 235.20%11.76M | ---- | -595.76%-8.7M | ---- | -153.26%-1.25M | ---- | 2,270.71%2.35M | ---- |
Accounts payable increase (decrease) | 4,562.81%5.4M | ---- | 99.17%-121K | ---- | -178.89%-14.66M | ---- | 647.51%18.58M | ---- | 251.59%2.49M | ---- |
prepayments (increase)decrease | 99.58%-7K | ---- | -586.67%-1.65M | ---- | 93.51%-240K | ---- | -10,976.47%-3.7M | ---- | -98.46%34K | ---- |
Special items for working capital changes | -225.23%-2.35M | ---- | 884.52%1.88M | ---- | -153.23%-239K | ---- | 283.27%449K | ---- | -137.46%-245K | ---- |
Cash from business operations | -151.94%-4.08M | ---- | 94.17%-1.62M | ---- | -853.89%-27.83M | ---- | 270.41%3.69M | ---- | 81.49%-2.17M | ---- |
Other taxs | 37.75%-94K | ---- | 13.71%-151K | ---- | -348.72%-175K | ---- | ---39K | ---- | ---- | ---- |
Special items of business | ---- | -357.60%-3.95M | ---- | 147.52%1.53M | ---- | 5.76%-3.23M | ---- | 56.27%-3.42M | ---- | -84.67%-7.83M |
Net cash from operations | -135.78%-4.18M | -357.60%-3.95M | 93.67%-1.77M | 147.52%1.53M | -866.73%-28M | 5.76%-3.23M | 268.61%3.65M | 56.27%-3.42M | 81.49%-2.17M | -84.67%-7.83M |
Cash flow from investment activities | ||||||||||
Interest received - investment | 850.00%19K | ---- | 0.00%2K | ---- | -81.82%2K | ---- | -73.17%11K | ---- | 17.14%41K | ---- |
Decrease in deposits (increase) | --2.01M | ---- | ---- | ---- | 589.47%93K | ---- | 47.22%-19K | ---- | -33.33%-36K | ---- |
Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --58K | ---- |
Purchase of fixed assets | 84.43%-52K | ---- | 53.16%-334K | ---- | 94.98%-713K | ---- | -818.49%-14.21M | ---- | 55.83%-1.55M | ---- |
Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---24K | ---- |
Other items in the investment business | ---- | 79.42%-50K | ---- | -151.37%-243K | ---- | 1,151.11%473K | ---- | 48.86%-45K | ---- | 96.42%-88K |
Net cash from investment operations | 694.88%1.98M | 79.42%-50K | 46.28%-332K | -151.37%-243K | 95.65%-618K | 1,151.11%473K | -842.77%-14.22M | 48.86%-45K | 56.84%-1.51M | 96.42%-88K |
Net cash before financing | -4.71%-2.2M | -410.00%-4M | 92.65%-2.1M | 146.86%1.29M | -170.88%-28.62M | 20.62%-2.75M | -187.56%-10.57M | 56.19%-3.47M | 75.82%-3.67M | -18.17%-7.92M |
Cash flow from financing activities | ||||||||||
New borrowing | --2.19M | ---- | ---- | ---- | 167.21%14.75M | ---- | --5.52M | ---- | ---- | ---- |
Refund | ---- | ---- | -66.24%-4.5M | ---- | -1,692.72%-2.71M | ---- | -3.42%-151K | ---- | 26.26%-146K | ---- |
Issuing shares | -37.70%7.87M | ---- | -52.14%12.64M | ---- | 202.06%26.4M | ---- | -7.10%8.74M | ---- | -27.63%9.41M | ---- |
Interest paid - financing | 55.79%-576K | ---- | 65.17%-1.3M | ---- | -29.31%-3.74M | ---- | -13.41%-2.89M | ---- | -94.44%-2.55M | ---- |
Issuance expenses and redemption of securities expenses | 88.12%-60K | ---- | 4.54%-505K | ---- | -71.75%-529K | ---- | -33.91%-308K | ---- | 44.84%-230K | ---- |
Other items of the financing business | ---- | 147.63%5.06M | ---- | -1.83%2.04M | ---- | 315.87%2.08M | ---- | -114.49%-964K | ---- | -46.46%6.65M |
Net cash from financing operations | 242.69%3.73M | 147.63%5.06M | -96.26%1.09M | -1.83%2.04M | 281.42%29.08M | 315.87%2.08M | 301.74%7.63M | -114.49%-964K | -83.78%1.9M | -46.46%6.65M |
Effect of rate | -879.37%-617K | 75.23%-403K | -400.00%-63K | -1,141.98%-1.63M | -43.24%21K | -103.92%-131K | 147.44%37K | 50.88%3.34M | 94.94%-78K | 156.99%2.21M |
Net Cash | 249.66%1.52M | -68.20%1.06M | -319.18%-1.02M | 595.98%3.33M | 115.78%464K | 84.84%-672K | -65.54%-2.94M | -250.63%-4.43M | 49.11%-1.78M | -122.08%-1.26M |
Begining period cash | -26.75%2.96M | -26.75%2.96M | 13.65%4.04M | 13.65%4.04M | -44.97%3.55M | -44.97%3.55M | -22.31%6.46M | -22.31%6.46M | -37.71%8.31M | -37.71%8.31M |
Cash at the end | 30.59%3.86M | -37.06%3.62M | -26.75%2.96M | 108.87%5.74M | 13.65%4.04M | -48.72%2.75M | -44.97%3.55M | -42.08%5.36M | -22.31%6.46M | -39.01%9.26M |
Cash balance analysis | ||||||||||
Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -22.31%6.46M | --9.26M |
Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -22.31%6.46M | --9.26M |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | Pioneer Accountants Ltd | -- | Pioneer Accountants Ltd | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data